Prostate-Specific AntigenProstatic NeoplasmsProstatectomyDigital Rectal ExaminationProstatic HyperplasiaProstateAndrogen AntagonistsBiopsy, NeedleBiopsyTumor Markers, BiologicalProstatic DiseasesTosyl CompoundsNeoplasm GradingUrologyLeuprolideAntineoplastic Agents, HormonalKallikreinsNomogramsNeoplasm StagingProstatic Intraepithelial NeoplasiaPredictive Value of TestsPrognosisBrachytherapyRetrospective StudiesNeoplasm Recurrence, LocalEstramustineFinasterideAnilidesAdenocarcinomaArthritis, PsoriaticOrchiectomyAndrogensEarly Detection of CancerReceptors, AndrogenBone NeoplasmsPalpationFollow-Up StudiesMass ScreeningTreatment OutcomeSensitivity and SpecificityTransurethral Resection of ProstateFlutamideDisease ProgressionProstatic Secretory ProteinsTestosteroneGoserelinSalvage TherapyNeoplasms, Hormone-DependentROC CurveCohort StudiesDisease-Free SurvivalSurvival AnalysisTime FactorsRadiotherapy, ConformalRisk FactorsMultivariate AnalysisCarcinomaRegression AnalysisRisk AssessmentCase-Control Studiesalpha 1-AntichymotrypsinSurvival RateTissue KallikreinsProspective StudiesNitrilesNeoplasm MetastasisAge FactorsProportional Hazards ModelsSwedenAsian Continental Ancestry GroupReference ValuesRadiotherapy DosageGonadotropin-Releasing HormoneIncidenceEuropean Continental Ancestry GroupOrgan SizeGenetic Predisposition to DiseaseAfrican AmericansReproducibility of ResultsPolymorphism, Single NucleotideAnalysis of VarianceMice, NudeLinear ModelsRiskBody Mass IndexFluoroimmunoassayImmunohistochemistryUnited StatesGenotypeAntineoplastic Combined Chemotherapy ProtocolsSialic AcidsObesityCell Line, TumorNeural Cell Adhesion MoleculesImmunoassayPsoriasisGlutamate Carboxypeptidase II